Opaleye Management Inc. bought GRCE

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001493152-26-050313

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 4, 2026

Published

Nov 5, 2026

Ingested by INSIDER

Nov 6, 03:18 UTC

Last re-read

Nov 6, 19:01 UTC

Extracted facts

Filer

Opaleye Management Inc.

Role

10% Owner

Transaction

Open-market purchaseAs filed: “P”

Asset

Grace Therapeutics, Inc.

Ticker

GRCE

Shares

5,027

Price per share

$1.8

Value

$9,060

Execution date (reported)

Nov 4, 2026

Owned after transaction

3.05M shares

Days from execution to publication

1

Calculation

What this establishes

Opaleye Management Inc. filed this Form 4 reporting a open-market purchase of GRCE on Nov 4, 2026. It became public on Nov 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

10% Owner

Opaleye Management Inc.cik:0001595855

Issuer

Grace Therapeutics, Inc.cik:0001444192

Revision history · 0

No field has changed since this record was first ingested.